Skip to main content
Clinical Trials/NCT04826835
NCT04826835RecruitingNot Applicable

A Prehabilitation Program to Boost Postoperative Functional Capacity in Surgical Lung Cancer Patients: a Randomized Controlled Trial

The University of Hong Kong1 site in 1 country198 target enrollmentStarted: May 14, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
198
Locations
1
Primary Endpoint
Change from baseline 6-minute walking distance from baseline to 3-month post-surgery

Study Overview

Brief Summary

This research study is evaluating a prehabiliation intervention designed to improve postoperative functional capacity (measured by 6-minure walking distance) in individuals undergoing lung resection for cancer.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
45 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients who are diagnosed of stage I, II, or IIIA Non-small-cell lung carcinoma (NSCLC) diagnosis, with or without pre-operative histologic confirmation
  • •Patients scheduled to undergo lung resection surgery at least two weeks from recruitment
  • •Patients with a Eastern Cooperative Oncology Group (ECOG) score of 0 or 1 at recruitment
  • •Patients with no evidence of recurrent or progressive disease
  • •Patients aged 45-80 years
  • •Patients able to communicate in Cantonese, Mandarin, or English
  • •Patients is absence of any cognitive impairment
  • •Patients with a score of 6 minutes walking test (6MWT) ≤ 500 meters at baseline. [rationale: a threshold value of 500 meters preoperative 6MWT predicts a higher risk of postoperative complications and prolonged LOS after lung resection]
  • •Engagement in less than 150 minutes of moderate aerobic activity per week in the past 3 months

Exclusion Criteria

  • •Patients who had engaged in at least 150 minutes of moderate aerobic activity or 75 minutes of vigorous aerobic activity per week in the past three months
  • •Presence of another concurrent, actively treated malignancy
  • •Presence of chronic obstructive pulmonary disease
  • •Presence of significant comorbidities that impede ability to engage in exercise, such as congestive heart failure, orthopedic disorders of the lower limbs, respiratory failure, or the need for portable oxygen therapy for activities of daily living
  • •Not having a smart device to receive WhatsApp messages

Arms & Interventions

Prehabilitation intervention

Experimental

Participants in the intervention group will follow a 2-week prehabilitation program before lung resection.

Intervention: Prehabilitation intervention (Behavioral)

Health education control

Active Comparator

Participants in the control group will receive health education classes during 2 weeks before lung resection.

Intervention: Health education control (Behavioral)

Outcomes

Primary Outcomes

Change from baseline 6-minute walking distance from baseline to 3-month post-surgery

Time Frame: Baseline; 3-month post-surgery

Secondary Outcomes

  • Physical activity self-efficacy (9-item Self-Efficacy for Exercise, SEE)(Baseline; 2 weeks (post-intervention); 1-month post-surgery; 3-month post-surgery)
  • Change from baseline 6-minute walking distance at 1-month post-surgery(Baseline; 1-months post-surgery)
  • Change from baseline functional assessment of cancer treatment - Lung (FACT-L) at post-intervention(Baseline; 2 weeks (post-intervention))
  • Change from baseline functional assessment of cancer treatment - Lung (FACT-L) at 1-month post-surgery(Baseline; 2 weeks (post-intervention); 1-month post-surgery)
  • Change from baseline daily step count measured by pedometer at 1-month post-surgery(Baseline; 1-month post-surgery)
  • Length of postoperative hospital stay(1-month post-surgery)
  • Change from baseline functional assessment of cancer treatment - Lung (FACT-L) at 3-months post-surgery(Baseline; 3-month post-surgery)
  • Change from baseline international physical activity questionnaire (IPAQ) at 3-month post-surgery(Baseline; 3-month post-surgery)
  • Change from baseline daily step count measured by pedometer at post-intervention(Baseline; 2 weeks (post-intervention))
  • Postoperative complication(1-month post-surgery)
  • Change from baseline international physical activity questionnaire (IPAQ) at post-intervention(Baseline; 2 weeks (post-intervention))
  • Change from baseline international physical activity questionnaire (IPAQ) at 1-month post-surgery(Baseline; 1-month post-surgery)
  • Financial toxicity (COmprehensive Score for financial Toxicity, COST questionnaire)(Baseline; 3-month post-surgery)
  • Return to work (investigator-designed questionnaire)(3-month post-surgery)
  • Health-related quality of life for the cost-effectiveness analysis (EuroQol- 5 Dimension, EQ-5D-5L)(Baseline; 2 weeks (post-intervention); 1-month post-surgery; 3-month post-surgery)
  • Change from baseline 6-minute walking distance at post-intervention(Baseline; 2 weeks (post-intervention))
  • Change from baseline daily step count measured by pedometer at 3-month post-surgery(Baseline; 3-month post-surgery)
  • Health-related quality of life for the cost-effectiveness analysis (EuroQol-Visual Analog Score, EQ-VAS)(Baseline; 2 weeks (post-intervention); 1-month post-surgery; 3-month post-surgery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Professor Chia-Chin Lin

Professor and Head

The University of Hong Kong

Study Sites (1)

Loading locations...

Similar Trials